| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 150, 1885-1891, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
MB Lopes, BD Gaylinn, MO Thorner and MH Stoler
Department of Pathology, University of Virginia Health Sciences Center, Charlottesville 22908, USA.
The growth hormone (GH)-releasing hormone receptor (GHRH-R) has been recently cloned and found to be a member of a new family of seven transmembrane receptors that includes secretin, vasoactive intestinal peptide, calcitonin, and corticotropin-releasing factor. GHRH-R mRNA has been demonstrated by Northern blot analyses to be present specifically in the anterior pituitary gland. To determine the precise cellular localization of this receptor in normal anterior pituitary and pituitary adenomas, GHRH-R mRNA was analyzed in 2 normal human pituitary glands and 16 human pituitary adenomas using in situ hybridization. GHRH-R was specifically localized in somatotroph cells in the normal pituitary. In the adenomas, all GH-producing adenomas originating from acromegalic patients demonstrated up-regulation of GHRH-R mRNA when compared with levels in the normal pituitary. Only one of five clinically nonfunctioning adenomas, a gonadotroph luteinizing hormone/follicle-stimulating hormone-positive adenoma, exhibited up- regulation of this receptor message. Adrenocorticotrophic hormone- secreting and prolactin-secreting adenomas did not express GHRH-R message. In summary, GHRH-R is specifically expressed in somatotrophs and GH-producing adenomas, suggesting that GHRH-R may influence GH release in adenomas similar to this receptor's actions in the normal somatotrophs and may be involved in the growth of GH-secreting adenomas.
This article has been cited by other articles:
 |
|
 |
|
  E. V. Dimaraki, W. F. Chandler, M. B. Brown, C. A. Jaffe, S. Y. Kim, R. Taussig, V. Padmanabhan, and A. L. Barkan The Role of Endogenous Growth Hormone-Releasing Hormone in Acromegaly J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2185 - 2190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Rubinek, M. Hadani, G. Barkai, S. Melmed, and I. Shimon Prolactin (PRL)-Releasing Peptide Stimulates PRL Secretion from Human Fetal Pituitary Cultures and Growth Hormone Release from Cultured Pituitary Adenomas J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2826 - 2830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-d. Peng, S. Park, M. R. Gadelha, K. T. Coschigano, J. J. Kopchick, L. A. Frohman, and R. D. Kineman The Growth Hormone (GH)-Axis of GH Receptor/Binding Protein Gene-Disrupted and Metallothionein-Human GH-Releasing Hormone Transgenic Mice: Hypothalamic Neuropeptide and Pituitary Receptor Expression in the Absence and Presence of GH Feedback Endocrinology, March 1, 2001; 142(3): 1117 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Park, J. Kamegai, T. A. Johnson, L. A. Frohman, and R. D. Kineman Modulation of Pituitary Somatostatin Receptor Subtype (sst1-5) Messenger Ribonucleic Acid Levels by Changes in the Growth Hormone Axis Endocrinology, October 1, 2000; 141(10): 3556 - 3563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Y. Osamura, S. Tahara, R. Kurotani, N. Sanno, A. Matsuno, and A. Teramoto Contributions of Immunohistochemistry and In Situ Hybridization to the Functional Analysis of Pituitary Adenomas J. Histochem. Cytochem., April 1, 2000; 48(4): 445 - 458. [Abstract] [Full Text]
|
|
|
|
|
|
M. M. Skinner, R. Nass, B. Lopes, E. R. Laws, and M. O. Thorner Growth Hormone Secretagogue Receptor Expression in Human Pituitary Tumors J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4314 - 4320. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Petersenn, A. C. Rasch, M. Heyens, and H. M. Schulte Structure and Regulation of the Human Growth Hormone-Releasing Hormone Receptor Gene Mol. Endocrinol., February 1, 1998; 12(2): 233 - 247. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
